If you haven’t got a reimbursement strategy, you haven’t got a business model.
Healthcare in the US is complex, and it’s only in recent years that medical technology entrepreneurs have identified ‘reimbursement’ as the most significant barrier to new technology adoption in the US market, ahead of FDA regulatory clearance and raising capital.
Reimbursement strategies can have a critical impact on the success of your medical device and of your company. As such, it is vital that reimbursement is well understood, carefully considered, and integrated early into product development and building the business case.
At this event, BioMelbourne Network in partnership with LaunchVic, will officially launch their 2019 medical technology founder education program Healthtech Reimbursement: Getting Paid in the USA – a customised program designed to educate founders and executives of medical technology startups on the fundamentals of reimbursement, health economics, and market strategy in the US. The program will bring US reimbursement experts to Melbourne to deliver a series of masterclass modules and also provides a unique opportunity for a select group of participants to travel to the US to meet directly with key players in Medical Alley, Minneapolis – the leading healthtech hub of the USA.
Throughout the evening attendees will have the opportunity to network with local and international medical technology professionals and meet and engage with US delegates from the Victorian Government VIP Week. Attendees will also hear from:
- BioMelbourne Network Representative about this unique educational opportunity, what your company can expect to gain from participation, and how you can apply to gain maximum advantage from the program.
- International guest speaker Frank Jaskulke, VP Intelligence at The Medical Alley Association, Minneapolis, about the complexities of the US healthcare landscape; the critical impact of reimbursement strategies; and the opportunity that awaits participants for the ‘Go-To-Market in the USA’ component of the program.
- International guest speaker Jeffrey (JD) Blank, Managing Director of TreeHouse Health, Minneapolis, who will provide insight on the US healthcare market from an investor perspective; the developing trends in the medical technology sector; and investor tips for medtech success.
Date: Thursday, 21 March 2019
Time: 3:45 pm – Registrations; 4:00–5:00 pm – Presentations and Q&A; 5:00–6:00 pm – Networking
Venue: The Goods Shed, 710 Collins Street, Melbourne
Cost: This is a free event.
This event is supported by
About our speakers
Frank Jaskulke, Vice President of Intelligence, The Medical Alley Association, Minneapolis, USA
Frank Jaskulke accelerates health technology businesses success as VP of Intelligence for the Medical Alley Association. Working with the leadership of global corporations, new ventures, investors, academics and service providers Frank provides corporate development, member service and policy analysis to accomplish the mission laid out by Medical Alley’s founders in 1984, “to better advance mankind’s ability to take care of itself.”
Frank started his career in the Minnesota House of Representatives and received his education at the University of Minnesota studying political science and policymaking.
Jeffrey (JD) Blank, Managing Director, TreeHouse Health, Minneapolis, USA
TreeHouse Health is an innovation centre designed to invest in emerging companies and facilitate innovation between large and emerging players in the industry.
JD is Managing Director at TreeHouse Health where he leads business development and is responsible for executing investments in portfolio companies. JD also oversees TreeHouse Health operations and serves as the primary liaison between portfolio companies, anchor tenants, and service providers.
JD has past experience sourcing, evaluating and executing investments in early-stage companies. He also has experience working in corporate Government Affairs.
JD is a graduate of Miami University with a degree in Political Science and Business Legal Studies and earned an MBA from the University of Minnesota’s Carlson School of Management.